- Home
- GPCR vs XPRO Comparison
GPCR vs XPRO Comparison
Compare GPCR & XPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPCR
- XPRO
- Stock Information
- Founded
- GPCR 2016
- XPRO 1938
- Country
- GPCR United States
- XPRO United States
- Employees
- GPCR N/A
- XPRO N/A
- Industry
- GPCR
- XPRO Oilfield Services/Equipment
- Sector
- GPCR
- XPRO Energy
- Exchange
- GPCR Nasdaq
- XPRO Nasdaq
- Market Cap
- GPCR 1.2B
- XPRO 1.5B
- IPO Year
- GPCR 2023
- XPRO 2013
- Fundamental
- Price
- GPCR $33.00
- XPRO $12.92
- Analyst Decision
- GPCR Strong Buy
- XPRO Buy
- Analyst Count
- GPCR 8
- XPRO 4
- Target Price
- GPCR $69.57
- XPRO $14.00
- AVG Volume (30 Days)
- GPCR 838.8K
- XPRO 1.2M
- Earning Date
- GPCR 11-06-2025
- XPRO 10-23-2025
- Dividend Yield
- GPCR N/A
- XPRO N/A
- EPS Growth
- GPCR N/A
- XPRO 313.92
- EPS
- GPCR N/A
- XPRO 0.59
- Revenue
- GPCR N/A
- XPRO $1,661,811,000.00
- Revenue This Year
- GPCR N/A
- XPRO N/A
- Revenue Next Year
- GPCR N/A
- XPRO $2.88
- P/E Ratio
- GPCR N/A
- XPRO $21.78
- Revenue Growth
- GPCR N/A
- XPRO N/A
- 52 Week Low
- GPCR $13.22
- XPRO $6.70
- 52 Week High
- GPCR $40.06
- XPRO $14.97
- Technical
- Relative Strength Index (RSI)
- GPCR 64.72
- XPRO 46.84
- Support Level
- GPCR $31.50
- XPRO $13.39
- Resistance Level
- GPCR $34.50
- XPRO $14.08
- Average True Range (ATR)
- GPCR 1.72
- XPRO 0.61
- MACD
- GPCR 0.29
- XPRO -0.10
- Stochastic Oscillator
- GPCR 85.30
- XPRO 20.25
About GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.
About XPRO Expro Group Holdings N.V.
Expro Group Holdings NV offers products and services that span the well life cycle, including well construction, well flow management, well intervention and integrity, and subsea well access. It maintains operations around the world and specializes in offshore production solutions. It also provides production optimization for both onshore and offshore applications. The company has four operating segments: North and Latin America (NLA); Europe and Sub-Saharan Africa (ESSA); Middle East and North Africa (MENA), and Asia-Pacific (APAC). The majority of its revenue is derived from North and Latin America (NLA) segment.